Skip to main content
Erschienen in: European Radiology 12/2022

14.06.2022 | Ultrasound

Evaluation of the diagnostic performance of the EFSUMB CEUS Pancreatic Applications guidelines (2017 version): a retrospective single-center analysis of 455 solid pancreatic masses

verfasst von: Wan-ying Jia, Yang Gui, Xue-qi Chen, Xiao-qian Zhang, Jia-hui Zhang, Meng-hua Dai, Jun-chao Guo, Xiao-yan Chang, Li Tan, Chun-mei Bai, Yue-juan Cheng, Jian-chu Li, Ke Lv, Yu-xin Jiang

Erschienen in: European Radiology | Ausgabe 12/2022

Einloggen, um Zugang zu erhalten

Abstract

Objectives

To explore the diagnostic performance of EFSUMB CEUS Pancreatic Applications guidelines (version 2017) before and after the addition of iso-enhancement and very fast/fast washout as supplementary diagnostic criteria for PDAC.

Methods

In this retrospective study, patients diagnosed with solid pancreatic lesions from January 2017 to December 2020 were evaluated. Pancreatic ductal adenocarcinoma (PDAC) is reported to show hypo-enhancement in all phases according to the EFSUMB guidelines. First, based on this definition, all lesions were categorized as PDAC and non-PDAC. Then, iso-enhancement and very fast/fast washout were added as supplementary diagnostic criteria, and all lesions were recategorized. The diagnostic performance was assessed in terms of the accuracy (ACC), sensitivity (SEN), specificity (SPE), positive predictive value (PPV), and negative predictive value (NPV). The reference standard consisted of histologic evaluation or composite imaging and clinical follow-up findings.

Results

A total of 455 nodules in 450 patients (median age, 58.37 years; 250 men) were included. The diagnostic performance using the EFSUMB CEUS guidelines for PDAC had an ACC of 69.5%, SEN of 65.4%, SPE of 84%, PPV of 93.5%, NPV of 40.6%, and ROC of 0.747. After recategorization according to the supplementary diagnostic criteria, the diagnostic performance for PDAC had an ACC of 95.8%, SEN of 99.2%, SPE of 84%, PPV of 95.7%, NPV of 96.6%, and ROC of 0.916.

Conclusion

The EFSUMB guidelines and recommendations for pancreatic lesions can effectively identify PDAC via hypo-enhancement on CEUS. However, the diagnostic performance may be further improved by the reclassification of PDAC lesions after adding iso-enhancement and very fast/fast washout mode.

Key Points

• In the EFSUMB guidelines, the only diagnostic criterion for PDAC is hypo-enhancement, to which iso-enhancement and very fast/fast washout mode were added in our research.
• Using hypo-enhancement/iso-enhancement with very fast/fast washout patterns as the diagnostic criteria for PDAC for solid pancreatic masses on CEUS has high diagnostic accuracy.
• The blood supply pattern of PDAC can provide important information, and CEUS has unique advantages in this respect due to its real-time dynamic attenuation ability.
Literatur
1.
Zurück zum Zitat Bartolotta TV, Randazzo A, Bruno E, Alongi P, Taibbi A (2021) Focal pancreatic lesions: role of contrast-enhanced ultrasonography. Diagnostics (Basel) 11:957CrossRefPubMed Bartolotta TV, Randazzo A, Bruno E, Alongi P, Taibbi A (2021) Focal pancreatic lesions: role of contrast-enhanced ultrasonography. Diagnostics (Basel) 11:957CrossRefPubMed
2.
Zurück zum Zitat Low G, Panu A, Millo N, Leen E (2011) Multimodality imaging of neoplastic and nonneoplastic solid lesions of the pancreas. Radiographics 31:993–1015CrossRefPubMed Low G, Panu A, Millo N, Leen E (2011) Multimodality imaging of neoplastic and nonneoplastic solid lesions of the pancreas. Radiographics 31:993–1015CrossRefPubMed
3.
Zurück zum Zitat Canivet C, Gourgou-Bourgade S, Napoléon B et al (2018) A prospective clinical and biological database for pancreatic adenocarcinoma: the BACAP cohort. BMC Cancer 18:986CrossRefPubMedCentralPubMed Canivet C, Gourgou-Bourgade S, Napoléon B et al (2018) A prospective clinical and biological database for pancreatic adenocarcinoma: the BACAP cohort. BMC Cancer 18:986CrossRefPubMedCentralPubMed
4.
Zurück zum Zitat Sidhu PS, Cantisani V, Dietrich CF et al (2018) The EFSUMB Guidelines and Recommendations for the clinical practice of Contrast-Enhanced Ultrasound (CEUS) in Non-Hepatic Applications: update 2017 (short version). Ultraschall Med 39:154–180CrossRefPubMed Sidhu PS, Cantisani V, Dietrich CF et al (2018) The EFSUMB Guidelines and Recommendations for the clinical practice of Contrast-Enhanced Ultrasound (CEUS) in Non-Hepatic Applications: update 2017 (short version). Ultraschall Med 39:154–180CrossRefPubMed
5.
Zurück zum Zitat D’Onofrio M, Zamboni G, Faccioli N, Capelli P, Pozzi Mucelli R (2007) Ultrasonography of the pancreas. 4. Contrast-enhanced imaging. Abdom Imaging 32:171–181CrossRefPubMed D’Onofrio M, Zamboni G, Faccioli N, Capelli P, Pozzi Mucelli R (2007) Ultrasonography of the pancreas. 4. Contrast-enhanced imaging. Abdom Imaging 32:171–181CrossRefPubMed
6.
Zurück zum Zitat D’Onofrio M, Malagò R, Zamboni G et al (2005) Contrast-enhanced ultrasonography better identifies pancreatic tumor vascularization than helical CT. Pancreatology 5:398–402CrossRefPubMed D’Onofrio M, Malagò R, Zamboni G et al (2005) Contrast-enhanced ultrasonography better identifies pancreatic tumor vascularization than helical CT. Pancreatology 5:398–402CrossRefPubMed
7.
Zurück zum Zitat D’Onofrio M, Canestrini S, De Robertis R et al (2015) CEUS of the pancreas: still research or the standard of care. Eur J Radiol 84:1644–1649CrossRefPubMed D’Onofrio M, Canestrini S, De Robertis R et al (2015) CEUS of the pancreas: still research or the standard of care. Eur J Radiol 84:1644–1649CrossRefPubMed
8.
Zurück zum Zitat Fan Z, Li Y, Yan K et al (2013) Application of contrast-enhanced ultrasound in the diagnosis of solid pancreatic lesions--a comparison of conventional ultrasound and contrast-enhanced CT. Eur J Radiol 82:1385–1390CrossRefPubMed Fan Z, Li Y, Yan K et al (2013) Application of contrast-enhanced ultrasound in the diagnosis of solid pancreatic lesions--a comparison of conventional ultrasound and contrast-enhanced CT. Eur J Radiol 82:1385–1390CrossRefPubMed
9.
Zurück zum Zitat Li XZ, Song J, Sun ZX, Yang YY, Wang H (2018) Diagnostic performance of contrast-enhanced ultrasound for pancreatic neoplasms: a systematic review and meta-analysis. Dig Liver Dis 50:132–138CrossRefPubMed Li XZ, Song J, Sun ZX, Yang YY, Wang H (2018) Diagnostic performance of contrast-enhanced ultrasound for pancreatic neoplasms: a systematic review and meta-analysis. Dig Liver Dis 50:132–138CrossRefPubMed
10.
Zurück zum Zitat Scialpi M, Reginelli A, D’Andrea A et al (2016) Pancreatic tumors imaging: an update. Int J Surg 28(Suppl 1):142–155CrossRef Scialpi M, Reginelli A, D’Andrea A et al (2016) Pancreatic tumors imaging: an update. Int J Surg 28(Suppl 1):142–155CrossRef
11.
Zurück zum Zitat Paiella S, Landoni L, Rota R et al (2020) Endoscopic ultrasound-guided fine-needle aspiration for the diagnosis and grading of pancreatic neuroendocrine tumors: a retrospective analysis of 110 cases. Endoscopy 52:988–994CrossRefPubMed Paiella S, Landoni L, Rota R et al (2020) Endoscopic ultrasound-guided fine-needle aspiration for the diagnosis and grading of pancreatic neuroendocrine tumors: a retrospective analysis of 110 cases. Endoscopy 52:988–994CrossRefPubMed
12.
Zurück zum Zitat Crinó SF, Brandolese A, Vieceli F et al (2021) Endoscopic ultrasound features associated with malignancy and aggressiveness of nonhypovascular solid pancreatic lesions: results from a prospective observational study. Ultraschall Med 42:167–177CrossRefPubMed Crinó SF, Brandolese A, Vieceli F et al (2021) Endoscopic ultrasound features associated with malignancy and aggressiveness of nonhypovascular solid pancreatic lesions: results from a prospective observational study. Ultraschall Med 42:167–177CrossRefPubMed
13.
Zurück zum Zitat Gincul R, Palazzo M, Pujol B et al (2014) Contrast-harmonic endoscopic ultrasound for the diagnosis of pancreatic adenocarcinoma: a prospective multicenter trial. Endoscopy 46:373–379CrossRefPubMed Gincul R, Palazzo M, Pujol B et al (2014) Contrast-harmonic endoscopic ultrasound for the diagnosis of pancreatic adenocarcinoma: a prospective multicenter trial. Endoscopy 46:373–379CrossRefPubMed
14.
Zurück zum Zitat Giovannini M, Caillol F, Monges G et al (2016) Endoscopic ultrasound-guided needle-based confocal laser endomicroscopy in solid pancreatic masses. Endoscopy 48:892–898CrossRefPubMed Giovannini M, Caillol F, Monges G et al (2016) Endoscopic ultrasound-guided needle-based confocal laser endomicroscopy in solid pancreatic masses. Endoscopy 48:892–898CrossRefPubMed
15.
Zurück zum Zitat Wang Y, Li G, Yan K et al (2021) Clinical value of contrast-enhanced ultrasound enhancement patterns for differentiating solid pancreatic lesions. Eur Radiol. 32:2060–2069CrossRefPubMed Wang Y, Li G, Yan K et al (2021) Clinical value of contrast-enhanced ultrasound enhancement patterns for differentiating solid pancreatic lesions. Eur Radiol. 32:2060–2069CrossRefPubMed
16.
Zurück zum Zitat Zhou T, Tan L, Gui Y et al (2021) Correlation between enhancement patterns on transabdominal ultrasound and survival for pancreatic ductal adenocarcinoma. Cancer Manag Res 13:6823–6832CrossRefPubMedCentralPubMed Zhou T, Tan L, Gui Y et al (2021) Correlation between enhancement patterns on transabdominal ultrasound and survival for pancreatic ductal adenocarcinoma. Cancer Manag Res 13:6823–6832CrossRefPubMedCentralPubMed
17.
Zurück zum Zitat D’Onofrio M, Zamboni G, Tognolini A et al (2006) Mass-forming pancreatitis: value of contrast-enhanced ultrasonography. World J Gastroenterol 12:4181–4184CrossRefPubMedCentralPubMed D’Onofrio M, Zamboni G, Tognolini A et al (2006) Mass-forming pancreatitis: value of contrast-enhanced ultrasonography. World J Gastroenterol 12:4181–4184CrossRefPubMedCentralPubMed
18.
Zurück zum Zitat Kitano M, Kudo M, Maekawa K et al (2004) Dynamic imaging of pancreatic diseases by contrast enhanced coded phase inversion harmonic ultrasonography. Gut 53:854–859CrossRefPubMedCentralPubMed Kitano M, Kudo M, Maekawa K et al (2004) Dynamic imaging of pancreatic diseases by contrast enhanced coded phase inversion harmonic ultrasonography. Gut 53:854–859CrossRefPubMedCentralPubMed
19.
Zurück zum Zitat Nagase M, Furuse J, Ishii H, Yoshino M (2003) Evaluation of contrast enhancement patterns in pancreatic tumors by coded harmonic sonographic imaging with a microbubble contrast agent. J Ultrasound Med 22:789–795CrossRefPubMed Nagase M, Furuse J, Ishii H, Yoshino M (2003) Evaluation of contrast enhancement patterns in pancreatic tumors by coded harmonic sonographic imaging with a microbubble contrast agent. J Ultrasound Med 22:789–795CrossRefPubMed
20.
Zurück zum Zitat Hocke M, Schulze E, Gottschalk P, Topalidis T, Dietrich CF (2006) Contrast-enhanced endoscopic ultrasound in discrimination between focal pancreatitis and pancreatic cancer. World J Gastroenterol 12:246–250CrossRefPubMedCentralPubMed Hocke M, Schulze E, Gottschalk P, Topalidis T, Dietrich CF (2006) Contrast-enhanced endoscopic ultrasound in discrimination between focal pancreatitis and pancreatic cancer. World J Gastroenterol 12:246–250CrossRefPubMedCentralPubMed
21.
Zurück zum Zitat Blouhos K, Boulas KA, Tsalis K, Hatzigeorgiadis A (2015) The isoattenuating pancreatic adenocarcinoma: review of the literature and critical analysis. Surg Oncol 24:322–328CrossRefPubMed Blouhos K, Boulas KA, Tsalis K, Hatzigeorgiadis A (2015) The isoattenuating pancreatic adenocarcinoma: review of the literature and critical analysis. Surg Oncol 24:322–328CrossRefPubMed
22.
Zurück zum Zitat Serra C, Felicani C, Mazzotta E et al (2013) Contrast-enhanced ultrasound in the differential diagnosis of exocrine versus neuroendocrine pancreatic tumors. Pancreas 42:871–877CrossRefPubMed Serra C, Felicani C, Mazzotta E et al (2013) Contrast-enhanced ultrasound in the differential diagnosis of exocrine versus neuroendocrine pancreatic tumors. Pancreas 42:871–877CrossRefPubMed
23.
Zurück zum Zitat Lee S, Kim SH, Park HK, Jang KT, Hwang JA, Kim S (2018) Pancreatic ductal adenocarcinoma: rim enhancement at MR imaging predicts prognosis after curative resection. Radiology 288:456–466CrossRefPubMed Lee S, Kim SH, Park HK, Jang KT, Hwang JA, Kim S (2018) Pancreatic ductal adenocarcinoma: rim enhancement at MR imaging predicts prognosis after curative resection. Radiology 288:456–466CrossRefPubMed
Metadaten
Titel
Evaluation of the diagnostic performance of the EFSUMB CEUS Pancreatic Applications guidelines (2017 version): a retrospective single-center analysis of 455 solid pancreatic masses
verfasst von
Wan-ying Jia
Yang Gui
Xue-qi Chen
Xiao-qian Zhang
Jia-hui Zhang
Meng-hua Dai
Jun-chao Guo
Xiao-yan Chang
Li Tan
Chun-mei Bai
Yue-juan Cheng
Jian-chu Li
Ke Lv
Yu-xin Jiang
Publikationsdatum
14.06.2022
Verlag
Springer Berlin Heidelberg
Erschienen in
European Radiology / Ausgabe 12/2022
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-022-08879-0

Weitere Artikel der Ausgabe 12/2022

European Radiology 12/2022 Zur Ausgabe

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.